ProMetic Life Sciences Inc. (PLI)(otcqx:PFSCF) (“ProMetic” or the “Corporation”) announced today that it has entered into an agreement for the acquisition of Emergent BioSolutions’ (“Emergent”) plasma collection center located in Winnipeg, Canada. The transaction is subject to customary closing conditions.
Emergent’s plasma collection center is an FDA and Health Canada licensed plasma collection facility. The plasma collection center is conveniently located in close proximity to the existing Emergent Winnipeg based cGMP manufacturing facility, which was recently announced as providing ProMetic with up to 250,000 liters of annual plasma processing capacity. The plasma collection center will start operating under ProMetic’s ownership upon granting of the regulatory licenses, in ProMetic’s name, by the requisite regulatory authorities. All existing center employees will then transition to be employed by ProMetic.